Saxenda

Product NDC: 50090-4257
11-digit product format: 500904257
Labeler code: 50090
Product ID: 50090-4257_f65e201b-a65f-4e28-af27-5292380ee09d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: liraglutide
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Labeler: A-S Medication Solutions
Application: NDA206321
Marketing category: NDA
Marketing start: 2014-12-31
Substance: LIRAGLUTIDE
Active strength: 6 mg/mL
Pharmacologic classes: GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N206321-001	SAXENDA	LIRAGLUTIDE	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS	AP2	RLD, RS	2014-12-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N206321-001	AP2

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N206321-001	8114833	2025-08-13		Drug product	2015-01-21
N206321-001	8114833*PED	2026-02-13		Pediatric extension
N206321-001	9968659	2037-01-09	U-2438		2018-11-16
N206321-001	9968659*PED	2037-07-09		Pediatric extension

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS	AP2	RLD, RS	2014-12-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS	AP2	RLD, RS	2014-12-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS	AP2	RLD, RS	2014-12-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N206321-001	SAXENDA	18MG/3ML (6MG/ML)	SOLUTION / SUBCUTANEOUS		RLD, RS	2014-12-23	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N206321-001	AP2	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206321-001	AP2	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206321-001	AP2	1	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N206321-001	AP2	1	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 36 · 1,424 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N206321-001	8114833	2025-08-13		Drug product	2015-01-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206321-001	8114833*PED	2026-02-13		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206321-001	9968659	2037-01-09	U-2438		2018-11-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N206321-001	9968659*PED	2037-07-09		Pediatric extension		`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N206321-001	8114833	2025-08-13		Drug product	2015-01-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206321-001	8114833*PED	2026-02-13		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206321-001	9968659	2037-01-09	U-2438		2018-11-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206321-001	9968659*PED	2037-07-09		Pediatric extension		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206321-001	8114833	2025-08-13		Drug product	2015-01-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206321-001	8114833*PED	2026-02-13		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206321-001	9968659	2037-01-09	U-2438		2018-11-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206321-001	9968659*PED	2037-07-09		Pediatric extension		`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206321-001	8114833	2025-08-13		Drug product	2015-01-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206321-001	8114833*PED	2026-02-13		Pediatric extension		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206321-001	9968659	2037-01-09	U-2438		2018-11-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206321-001	9968659*PED	2037-07-09		Pediatric extension		`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	8114833	2025-08-13		Drug product	2015-01-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	11446443	2025-10-20		Drug product	2022-10-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	8684969	2025-10-20		Drug product	2015-01-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	10357616	2026-01-20		Drug product	2019-08-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	10376652	2026-01-20		Drug product	2019-09-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	11311679	2026-01-20		Drug product	2022-05-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9616180	2026-01-20		Drug product	2018-08-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9861757	2026-01-20		Drug product	2018-08-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9108002	2026-01-26		Drug product	2015-09-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	8114833*PED	2026-02-13		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	8684969*PED	2026-04-20		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	10220155	2026-07-17		Drug product	2019-04-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	11097063	2026-07-17		Drug product	2021-09-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	8920383	2026-07-17		Drug product	2015-02-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9775953	2026-07-17		Drug product	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9616180*PED	2026-07-20		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9861757*PED	2026-07-20		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9108002*PED	2026-07-26		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	RE46363	2026-08-03		Drug product	2017-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	10220155*PED	2027-01-17		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	8920383*PED	2027-01-17		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9775953*PED	2027-01-17		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	RE46363*PED	2027-02-03		Pediatric extension		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206321-001	9687611	2027-02-27		Drug product	2017-09-06	`fd3edfee7708…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206321-001	NPP	2023-12-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206321-001	NPP	2023-12-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206321-001	NPP	2023-12-04	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N206321-001	NPP	2023-12-04	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N206321-001	NPP	2023-12-04	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N206321-001	NPP	2023-12-04	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N206321-001	NPP	2023-12-04	`5aa47cf7b7d7…`
2023-12-20 04:57 UTC	2023-12	N206321-001	NPP	2023-12-04	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N206321-001	NPP	2023-12-04	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N206321-001	NPP	2023-12-04	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N206321-001	NPP	2023-12-04	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N206321-001	NPP	2023-12-04	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N206321-001	NPP	2023-12-04	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N206321-001	NPP	2023-12-04	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N206321-001	NPP	2023-12-04	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N206321-001	NPP	2023-12-04	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N206321-001	NPP	2023-12-04	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N206321-001	NPP	2023-12-04	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Saxenda
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LIRAGLUTIDE	6 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
839I73S42A	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1598268	Internal RxNorm lookup
2735350	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d8dac6c8-0045-42cf-b357-c3350b4ada5c	Product name	2	20251021
0dd952e2-ff48-4739-9b8d-72ae0b326834	Product name	2	20200323
ce962b7e-f9f8-43e6-8d30-41514e79f3e4	Product name	1	20190201
2f360a13-6ea8-4c2b-b2ef-10133c2836d9	Product name	1	20150316

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-4257-0	2024-01-29	C162847	48780-1	f386c649-de7e-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010
50090-4257-0	2023-01-30	C162847	48780-1	f386c649-de7e-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-4257-0	Saxenda	3 mL in 1 SYRINGE, PLASTIC	INJECTION, SOLUTION	3		6
50090-4257-0	Saxenda	5 in 1 CARTON	INJECTION, SOLUTION	5		6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-4257-0	ML - Milliliter	50090-4257	6987eafd-0586-4701-8845-3cb1fcc5a69f	1	2022-04-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-4257	SAXENDA (LIRAGLUTIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS]	6	Current NDC, Legacy NDC, 2 package rows	20240131_7b11f6ac-4c27-4748-9e65-22d4cf3adfb4.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Saxenda	LIRAGLUTIDE	Novo Nordisk Pharmaceutical Industries, LP	3946d389-0926-4f77-a708-0acb8153b143	2026-02-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 206321 application number: NDA206321
Saxenda	LIRAGLUTIDE	A-S Medication Solutions	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	2024-01-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 206321 application number: NDA206321 ndc (product): 50090-4257

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
839I73S42A	LIRAGLUTIDE	204656-20-2	LIRAGLUTIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2735350	liraglutide 6 MG/ML in 3 mL Weight Management Pen Injector	PSN	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
1598268	Saxenda 6 MG/ML in 3 mL Weight Management Pen Injector	PSN	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
1598268	Weight Management 3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]	SBD	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
2735350	Weight Management 3 ML liraglutide 6 MG/ML Pen Injector	SCD	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
1598268	3 ML Saxenda 6 MG/ML Weight Management Pen Injector	SY	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
2735350	liraglutide 18 MG per 3 ML Weight Management Pen Injector	SY	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
1598268	Saxenda 18 MG per 3 ML Weight Management Pen Injector	SY	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6
1598268	Weight Management Saxenda 6 MG/ML Pen Injector	SY	7b11f6ac-4c27-4748-9e65-22d4cf3adfb4	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-4257-0	50090425700	5 SYRINGE, PLASTIC in 1 CARTON (50090-4257-0) / 3 mL in 1 SYRINGE, PLASTIC	2019-04-09	0000-00-00	No	No	Current